Masud, Tehmina
Soong, Charles
Xu, Hong
Biele, Justina
Bjornson, Saelin
McKinney, Steven
Aparicio, Samuel
Funding for this research was provided by:
Stand Up To Cancer (SU2C-AACR-DT-18-15, SU2C-AACR-DT-18-15)
BC Cancer Foundation
Terry Fox Research Institute (1082)
Canadian Cancer Society Research Institute (705617)
CIHR (FDN-148429)
Canada Research Chair
Article History
Received: 21 May 2020
Accepted: 9 April 2021
First Online: 7 May 2021
Competing interests
: S.A. is a founder and shareholder of Canexia Healthcare Inc. S.A. is a scientific advisor to Repare Therapeutics, Sangamo Pharmaceuticals and Cerevance. The other authors have no competing interest.